History of Zenith Alpha Thoracic

Since 1963, Cook Medical has been committed to helping physicians treat their patients with aortic disease. This commitment led to Cook’s legacy of creative, durability-by-design product development.

This low-profile graft is indicated for the endovascular treatment of patients with aneurysms or ulcers of the descending thoracic aorta having vascular morphology suitable for endovascular repair.*

With the next decade of Zenith Alpha Thoracic will come some exciting updates. Stay tuned!

Read here to learn about how this graft can treat more patients with TEVAR, the variety of sizing options, its intuitive introduction system, and much more.

*Vascular anatomy suitable for endovascular repair includes nonaneurysmal aortic segments (fixation sites) proximal and distal to the thoracic lesion with a length of at least 20 mm, and with a diameter measured outer wall to outer wall of no greater than 42 mm and no less than 20 mm.

Notable developments in the history of Zenith Alpha Thoracic

All physicians are paid consultants of Cook Medical.